Literature DB >> 9038757

Expression of the alpha 5 beta 1 fibronectin receptor on T lymphocytes of patients with HIV-1 infection.

D Torre1, G Ferrario, M Issi, A Pugliese, F Speranza.   

Abstract

AIMS: To evaluate the expression of the alpha 5 beta 1 integrin fibronectin receptor (FNR), which mediates several processes, including phagocytosis, cell motility and the immune response, on T lymphocytes of patients with HIV-1 infection.
METHODS: T lymphocytes were incubated with monoclonal antibody directed against FNR and then with monoclonal antibodies, conjugated with phycoerythrin, directed against CD3, CD4 and CD8 positive cells. Expression of FNR on CD3, CD4 and CD8 positive cells was analysed using flow cytometry.
RESULTS: Normal expression of FNR was observed on CD3 positive cells from asymptomatic HIV positive patients and those with AIDS. Increased expression of FNR was observed on CD8 positive cells from asymptomatic HIV positive patients and on CD4 positive cells from patients with AIDS. Increased FNR expression was observed on CD4 positive cells from patients with AIDS, particularly those with opportunistic infections caused by Pneumocystis carinii, Mycobacterium sp, Toxoplasma gondii, and Cryptococcus neoformans.
CONCLUSION: Increased expression of FNR on CD8 and CD4 positive cells in asymptomatic HIV positive patients and those with AIDS, respectively, may be an epiphenomenon correlated with lymphocyte activation by HIV-1 or opportunistic infection, Further study is required to determine whether upregulation of FNR expression has a direct role in the pathogenesis of AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9038757      PMCID: PMC500722          DOI: 10.1136/jcp.49.9.733

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

Review 1.  New perspectives in cell adhesion: RGD and integrins.

Authors:  E Ruoslahti; M D Pierschbacher
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

Review 2.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  Plasma fibronectin concentrations in patients with human immunodeficiency virus infection.

Authors:  D Torre; M Issi; C Sampietro; G P Fiori; G Chelazzi; G Ferraro
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

4.  Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts.

Authors:  C J Roberts; T M Birkenmeier; J J McQuillan; S K Akiyama; S S Yamada; W T Chen; K M Yamada; J A McDonald
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

Review 5.  T cell fibronectin and mycobacterial adversarial strategy.

Authors:  H P Godfrey
Journal:  Int J Clin Lab Res       Date:  1993

6.  Fibronectin binds to Staphylococcus aureus.

Authors:  P Kuusela
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

Review 7.  T cell fibronectin: an unexpected inflammatory lymphokine.

Authors:  H P Godfrey
Journal:  Lymphokine Res       Date:  1990

8.  Interaction of human plasma fibronectin with viral proteins of human immunodeficiency virus.

Authors:  D Torre; A Pugliese; G Ferrario; G Marietti; B Forno; C Zeroli
Journal:  FEMS Immunol Med Microbiol       Date:  1994-02

9.  Mesoderm induction and the control of gastrulation in Xenopus laevis: the roles of fibronectin and integrins.

Authors:  J C Smith; K Symes; R O Hynes; D DeSimone
Journal:  Development       Date:  1990-02       Impact factor: 6.868

10.  Activation of the alpha 4 beta 1 integrin through the beta 1 subunit induces recognition of the RGDS sequence in fibronectin.

Authors:  P Sánchez-Aparicio; C Dominguez-Jiménez; A Garcia-Pardo
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

View more
  1 in total

Review 1.  Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.

Authors:  Aurelio Cafaro; Antonella Tripiciano; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Stefano Buttò; Paolo Monini; Barbara Ensoli
Journal:  Vaccines (Basel)       Date:  2019-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.